fda glp-1 warning news november 2025 Last month, the issued 25 letters to telehealth companies over what it called false or misleading claims about compounded medications. Read more at the link in the comments below FDA Issues 30 Warning Letters

In clinical trials, retatrutide has been administered using syringes or multidose prefilled pens ( Kwikpens )

Better You Rx is located outside of the USA and does not accept US-based insurance

If your FSA or HSA card is declined, you may complete your purchase using another payment method and contact [email protected] to request available documentation that may assist with reimbursement, subject to your plans requirements

Currently, theres no official retatrutide dosing information because the medication hasnt been approved yet by the United States Food and Drug Administration (FDA) and is not yet commercially available